Rankings
▼
Calendar
ESLA FY 2020 Earnings — Estrella Immunopharma, Inc. Revenue & Financial Results | Market Cap Arena
ESLA
Estrella Immunopharma, Inc.
$53M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$733,693
Net Income
-$733,693
EPS (Diluted)
$-0.02
Cash Flow
Operating Cash Flow
-$670,820
Free Cash Flow
-$670,820
Stock-Based Comp.
$62,873
← Q2 2021
All Quarters
